Thus, in HD patients with high PTH levels, continuous elevated PTH may suppress the expression of the SOST gene, reducing the secretion of sclerostin and consequently leading to the loss of its hypothetical defensive cardiovascular effect (Figure 2). This evidence concerns the gene PTH and Huntington disease.